Medifast Inc. (MED) Financials Nov 17, 2014, 4:23 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Medifast Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 165.62M 257.55M 298.19M 356.71M 356.89M
Cost of Goods Sold (COGS) incl. D&A 41.93M 65.37M 74.15M 89.24M 89.47M
COGS excluding D&A 36.66M 59.52M 65.81M 78.04M 78.09M
Depreciation & Amortization Expense 5.27M 5.86M 8.34M 11.21M 11.38M
Depreciation - 5.57M 7.89M 10.63M 10.95M
Amortization of Intangibles - 291,000 456,000 572,000 428,000
Gross Income 123.69M 192.18M 224.04M 267.46M 267.42M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense - 160.54M 196.66M 244.2M 231.7M
Research & Development - 0 0 0 0
Other SG&A - 160.54M 196.66M 244.2M 231.7M
Other Operating Expense - 0 0 0 0
Unusual Expense - 0 0 0 2.13M
EBIT after Unusual Expense - 0 0 0 (2.13M)
Non Operating Income/Expense - (222,000) (21,000) 895,000 91,000
Non-Operating Interest Income - 385,000 421,000 301,000 506,000
Equity in Affiliates (Pretax) - 0 0 - 0
Interest Expense 145,000 111,000 102,000 0 -
Gross Interest Expense 145,000 111,000 102,000 0 -
Interest Capitalized - - 0 - -
Pretax Income 19.29M 31.69M 27.68M 24.46M 34.19M
Income Tax - 12.08M 9.14M 8.58M 10.22M
Income Tax - Current Domestic - 12.15M 3.12M 9.92M 11.11M
Income Tax - Current Foreign - 0 0 - -
Income Tax - Deferred Domestic - (70,000) 6.02M (1.34M) (888,000)
Income Tax - Deferred Foreign - 0 0 - -
Income Tax Credits - 0 0 - 0
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - - 0 0 0
Consolidated Net Income 11.96M 19.61M 18.54M 15.88M 23.97M
Minority Interest Expense - 0 0 0 0
Net Income 11.96M 19.61M 18.54M 15.88M 23.97M
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries 11.96M 19.61M 18.54M 15.88M 23.97M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common - 19.61M 18.54M 15.88M 23.97M
EPS (Basic) 0.89 1.39 1.33 1.16 1.74
Basic Shares Outstanding 13.52M 14.08M 13.97M 13.72M 13.77M
EPS (Diluted) 0.81 1.35 1.31 1.16 1.73
Diluted Shares Outstanding 14.74M 14.57M 14.2M 13.72M 13.82M
EBITDA - 37.5M 35.73M 34.47M 47.1M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Medifast Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 165.62M 257.55M 298.19M 356.71M 356.89M
Cost of Goods Sold (COGS) incl. D&A 41.93M 65.37M 74.15M 89.24M 89.47M
COGS excluding D&A 36.66M 59.52M 65.81M 78.04M 78.09M
Depreciation & Amortization Expense 5.27M 5.86M 8.34M 11.21M 11.38M
Depreciation - 5.57M 7.89M 10.63M 10.95M
Amortization of Intangibles - 291,000 456,000 572,000 428,000
Gross Income 123.69M 192.18M 224.04M 267.46M 267.42M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense - 160.54M 196.66M 244.2M 231.7M
Research & Development - 0 0 0 0
Other SG&A - 160.54M 196.66M 244.2M 231.7M
Other Operating Expense - 0 0 0 0
Unusual Expense - 0 0 0 2.13M
EBIT after Unusual Expense - 0 0 0 (2.13M)
Non Operating Income/Expense - (222,000) (21,000) 895,000 91,000
Non-Operating Interest Income - 385,000 421,000 301,000 506,000
Equity in Affiliates (Pretax) - 0 0 - 0
Interest Expense 145,000 111,000 102,000 0 -
Gross Interest Expense 145,000 111,000 102,000 0 -
Interest Capitalized - - 0 - -
Pretax Income 19.29M 31.69M 27.68M 24.46M 34.19M
Income Tax - 12.08M 9.14M 8.58M 10.22M
Income Tax - Current Domestic - 12.15M 3.12M 9.92M 11.11M
Income Tax - Current Foreign - 0 0 - -
Income Tax - Deferred Domestic - (70,000) 6.02M (1.34M) (888,000)
Income Tax - Deferred Foreign - 0 0 - -
Income Tax Credits - 0 0 - 0
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - - 0 0 0
Consolidated Net Income 11.96M 19.61M 18.54M 15.88M 23.97M
Minority Interest Expense - 0 0 0 0
Net Income 11.96M 19.61M 18.54M 15.88M 23.97M
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries 11.96M 19.61M 18.54M 15.88M 23.97M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common - 19.61M 18.54M 15.88M 23.97M
EPS (Basic) 0.89 1.39 1.33 1.16 1.74
Basic Shares Outstanding 13.52M 14.08M 13.97M 13.72M 13.77M
EPS (Diluted) 0.81 1.35 1.31 1.16 1.73
Diluted Shares Outstanding 14.74M 14.57M 14.2M 13.72M 13.82M
EBITDA - 37.5M 35.73M 34.47M 47.1M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
